The Effect of Quantitative EEG Combined With Ultrasound and Sputum Volume on Predicting Weaning Failure

Launched by QINGDAO UNIVERSITY · Apr 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well certain tests can predict whether neurocritical patients will successfully have their breathing tubes removed, a process called extubation. Neurocritical patients often need breathing support but may face challenges due to their neurological conditions, even if their lungs are in better shape. The trial will look at three key indicators: a test called quantitative EEG to assess the patient's level of consciousness, ultrasound to check how well their breathing muscles are working, and the amount of sputum (mucus) produced, which can indicate lung health. The goal is to see if using these three indicators together can provide a better prediction of extubation success for these patients.

To be eligible for this trial, participants must be neurocritical patients who currently have a breathing tube in place, and they must have shown some ability to breathe on their own during a test called a spontaneous breathing trial. They also need to meet specific extubation criteria set by their doctors. It’s important to note that patients whose families have decided to stop treatment will not be able to participate. If chosen, participants can expect to undergo these assessments to help improve the understanding of how to safely remove breathing tubes in neurocritical patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Neurocritical patients with endotracheal intubation;
• • Successful spontaneous Breathing Trial;
• • The patients meet extubation criteria evaluated by clinical physician
• Exclusion Criteria:
• • Patients whose families have opted for cessation of treatment.